Immunogenicity Risk Assessment for Multi-specific Therapeutics

por Kroenke, Mark A., Milton, Mark N., Kumar, Seema, Bame, Eris, White, Joleen T.
Publicado 2021

Nonclinical Safety Evaluation of scAAV8-RLBP1 for Treatment of RLBP1 Retinitis Pigmentosa

por MacLachlan, Timothy K., Milton, Mark N., Turner, Oliver, Tukov, Francis, Choi, Vivian W., Penraat, Jan, Delmotte, Marie-Hélène, Michaut, Lydia, Jaffee, Bruce D., Bigelow, Chad E.
Publicado 2017